《内科学年鉴》发布LivaNova阻塞性睡眠呼吸暂停Osprey临床研究12个月结果

美股速递04-21

国际权威医学期刊《内科学年鉴》正式刊发了LivaNova公司针对阻塞性睡眠呼吸暂停开展的Osprey临床研究的12个月随访数据。该研究旨在评估治疗方案对患者长期疗效与安全性的影响，此次公布的结果为医疗界提供了重要临床证据。

作为专注于创新医疗技术的全球性企业，LivaNova通过这项前瞻性研究进一步夯实了其在睡眠呼吸疾病治疗领域的技术积累。最新数据将有助于推动相关疗法的标准化应用，为临床医生制定个体化治疗方案提供参考依据。

（注：Osprey研究聚焦于阻塞性睡眠呼吸暂停这一常见睡眠障碍疾病，其长期随访结果对改善患者生活质量和降低并发症风险具有重要意义）

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1119232003?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-04-21 05:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119232003","market":"us","top_or_hot":-1,"title":"《内科学年鉴》发布LivaNova阻塞性睡眠呼吸暂停Osprey临床研究12个月结果","media":"美股速递","content":"<p>国际权威医学期刊《内科学年鉴》正式刊发了LivaNova公司针对阻塞性睡眠呼吸暂停开展的Osprey临床研究的12个月随访数据。该研究旨在评估治疗方案对患者长期疗效与安全性的影响，此次公布的结果为医疗界提供了重要临床证据。</p>\n<p>作为专注于创新医疗技术的全球性企业，LivaNova通过这项前瞻性研究进一步夯实了其在睡眠呼吸疾病治疗领域的技术积累。最新数据将有助于推动相关疗法的标准化应用，为临床医生制定个体化治疗方案提供参考依据。</p>\n<p>（注：Osprey研究聚焦于阻塞性睡眠呼吸暂停这一常见睡眠障碍疾病，其长期随访结果对改善患者生活质量和降低并发症风险具有重要意义）</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>《内科学年鉴》发布LivaNova阻塞性睡眠呼吸暂停Osprey临床研究12个月结果</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n《内科学年鉴》发布LivaNova阻塞性睡眠呼吸暂停Osprey临床研究12个月结果\n</h2>\n\n<h4 class=\"meta\">\n\n2026-04-21 05:05 北京时间&nbsp;&nbsp;&nbsp;<strong>美股速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>国际权威医学期刊《内科学年鉴》正式刊发了LivaNova公司针对阻塞性睡眠呼吸暂停开展的Osprey临床研究的12个月随访数据。该研究旨在评估治疗方案对患者长期疗效与安全性的影响，此次公布的结果为医疗界提供了重要临床证据。\n作为专注于创新医疗技术的全球性企业，LivaNova通过这项前瞻性研究进一步夯实了其在睡眠呼吸疾病治疗领域的技术积累。最新数据将有助于推动相关疗法的标准化应用，为临床医生制定...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2065171311.SGD","symbol_name":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","start_time":0,"source_url":"","article_id":"1119232003","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119232003","pubTimestamp":1776719114,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"国际权威医学期刊《内科学年鉴》正式刊发了LivaNova公司针对阻塞性睡眠呼吸暂停开展的Osprey临床研究的12个月随访数据。该研究旨在评估治疗方案对患者长期疗效与安全性的影响，此次公布的结果为医疗界提供了重要临床证据。\n作为专注于创新医疗技术的全球性企业，LivaNova通过这项前瞻性研究进一步夯实了其在睡眠呼吸疾病治疗领域的技术积累。最新数据将有助于推动相关疗法的标准化应用，为临床医生制定个体化治疗方案提供参考依据。\n（注：Osprey研究聚焦于阻塞性睡眠呼吸暂停这一常见睡眠障碍疾病，其长期随访结果对改善患者生活质量和降低并发症风险具有重要意义）","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC","LIVN":"LivaNova PLC","BK4082":"医疗保健设备","LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC"},"translate_title":"Annals of Internal Medicine Releases 12-Month Results of LivaNova Obstructive Sleep Apnea Osprey Clinical Study","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LIVN":1},"content_text":"国际权威医学期刊《内科学年鉴》正式刊发了LivaNova公司针对阻塞性睡眠呼吸暂停开展的Osprey临床研究的12个月随访数据。该研究旨在评估治疗方案对患者长期疗效与安全性的影响，此次公布的结果为医疗界提供了重要临床证据。\n作为专注于创新医疗技术的全球性企业，LivaNova通过这项前瞻性研究进一步夯实了其在睡眠呼吸疾病治疗领域的技术积累。最新数据将有助于推动相关疗法的标准化应用，为临床医生制定个体化治疗方案提供参考依据。\n（注：Osprey研究聚焦于阻塞性睡眠呼吸暂停这一常见睡眠障碍疾病，其长期随访结果对改善患者生活质量和降低并发症风险具有重要意义）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1119232003","isCrawlerRequest":true}